BioVaxys Technology Corp. (BVAXF)
Develops cancer and infectious disease vaccines using immune-educating technology platforms.
$0.11-0.06%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-42.4%
The outlook
BVAXYS trades at $0.11, sitting well below both its 50- and 200-day moving averages. The stock sits in the lower portion of its 52-week range, and analyst coverage appears limited. Overall sentiment leans bearish based on current market positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range37% of the way from its 52-week low to high
Market cap
$4.6M
52-wk high
$0.27
52-wk low
$0.02
50-day avg
$0.14
200-day avg
$0.13
Trailing P/E
—